Found 5 matching trials
Safety and Efficacy of BiTE in Desensitization Therapy for Highly Sensitized Kidney Transplant Candidates With cPRA ≥ 90%
PHASE4This study is a prospective, open-label, two-arm exploratory clinical trial...
Location
Multiple Locations
Safety and Efficacy of the Bispecific T-Cell Engager (BiTE) in Kidney Transplant Recipients With Chronic Active Antibody-Mediated Rejection
PHASE4This clinical trial aims to determine whether a bispecific T-cell engager (...
Location
West China Hospital, Sichuan University
ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Primary Plasma Cell Leukemia
PHASE2This is a prospective, single-arm, phase II study to evaluate the efficacy ...
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma
PHASE2This is a prospective, single-center, clinical study to evaluate the effica...
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multiple Myeloma
PHASE2This is a prospective, single-arm, phase II study to evaluate the efficacy ...
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences